![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1608840
¼¼°èÀÇ Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ½ÃÀå ÇöȲPlatelet Aggregation Devices Market, By Product, By Application, By End User (Hospitals, Diagnostic Laboratories, and Others ), By Geography |
Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀåÀº 2024³â 6¾ï 1,170¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. 2024³âºÎÅÍ 2031³â±îÁö 6.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 2031³â¿¡´Â 9¾ï 5,970¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¸°í ¹üÀ§ | º¸°í¼ »ó¼¼³»¿ë | ||
---|---|---|---|
±âÁØ ¿¬µµ | 2023³â | 2024³â ½ÃÀå ±Ô¸ð | 6¾ï1,170¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2019-2023³â | ¿¹Ãø ±â°£ | 2024-2031³â |
¿¹Ãø ±â°£(2024-2031³â) CAGR: | 6.60% | 2031³â °¡Ä¡ ¿¹Ãø | 9¾ï 5,970¸¸ ´Þ·¯ |
Ç÷¼ÒÆÇ ÀÀÁý ±â±â´Â Ç÷¼ÒÆÇ Àå¾ÖÀÇ Áø´ÜÀ» µ½±â À§ÇØ ÀÓ»ó ÇöÀå¿¡¼ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Ç÷¼ÒÆÇÀº Ç÷¾× ÀÀ°í °úÁ¤¿¡ ÇʼöÀûÀ̸ç, Ç÷¼ÒÆÇ ±â´É¿¡ ÀÌ»óÀÌ ÀÖÀ¸¸é ÃâÇ÷°ú Ç÷Àü Çü¼ºÀÇ À§ÇèÀÌ Áõ°¡ÇÕ´Ï´Ù. Ç÷¼ÒÆÇ ÀÀÁý ¿ä¼Ò´Â ´Ù¾çÇÑ ÀÛ¿ëÁ¦¿¡ ¹ÝÀÀÇÏ¿© ÀÀÁýÇÏ´Â ´É·ÂÀ» ÃøÁ¤ÇÏ¿© Ç÷¼ÒÆÇÀÇ ±â´ÉÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀ¸·Î ¹Î°¨µµ¿Í ÀçÇö¼ºÀÌ Çâ»óµÈ ÀÚµ¿ÈµÈ °í󸮷® °Ë»ç°¡ °¡´ÉÇØÁ³½À´Ï´Ù. Ç÷¼ÒÆÇ Àå¾Ö¸¦ ¼±º°Çϰí Ç×Ç÷¼ÒÆÇ Ä¡·á¸¦ ÃÖÀûÈÇÏ´Â µ¥ µµ¿òÀÌ µÇ±â ¶§¹®¿¡ Ç÷¼ÒÆÇ ÀÀÁý ¿ä¼Ò¿¡ ´ëÇÑ ¼ö¿ä´Â ¸Å¿ì Å®´Ï´Ù.
Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀÌ¿¡ µû¸¥ Ç×Ç÷¼ÒÆÇÁ¦ »ç¿ë Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ, »õ·Î¿î ±â±âÀÇ °í±Þ ±â´ÉÀº ¿öÅ©Ç÷ο츦 °³¼±ÇÏ°í ¼öµ¿ °Ë»ç¿¡¼ ÀÚµ¿ °Ë»ç¹ýÀ¸·ÎÀÇ ÀüȯÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ±×·¯³ª ÀÚµ¿ Ç÷¼ÒÆÇ ºÐ¼®±â ½ÃÀåÀº ³ôÀº ºñ¿ë°ú ±âÁ¸ ¼³Ä¡ ±â¹ÝÀ» ´ëüÇÏ´Â µ¥ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ÀӽŠÁß Ç×Ç÷¼ÒÆÇ ¿ä¹ý ¸ð´ÏÅ͸µ, ÇöÀå Áø·á¿ë Ç¥ÁØÈµÈ °Ë»ç ÇÁ·ÎÅäÄÝ °³¹ß µî ÀÀ¿ë ºÐ¾ß È®´ë´Â ¼ºÀå ±âȸ°¡ µÉ ¼ö ÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
ÀÌ º¸°í¼´Â ¼¼°è Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çϰí 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ¿¹ÃøÇÑ º¸°í¼ÀÔ´Ï´Ù.
¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä °íÂûµµ Á¦°øÇÕ´Ï´Ù.
¼¼°è Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±âÁØÀ¸·Î Á¤¸®Çß½À´Ï´Ù.
ÁÖ¿ä ±â¾÷À¸·Î´Â Sysmex Corporation, WerfenLife SA, Siemens Healthineers, Sentinel Ch. SpA, Haemonetics Corporation, Chrono-Log Corporation, Bio/Data Corporation, Agredyne Inc., F. Hoffmann-La Roche Ltd., Helena Laboratories Corporation µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¼¼°è Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç °áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.
Platelet aggregation devices market is estimated to be valued at USD 611.7 Mn in 2024 and is expected to reach USD 959.7 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | 611.7 Mn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 6.60% | 2031 Value Projection: | 959.7 Mn |
Platelet aggregation devices are used in clinical settings to aid in diagnosis of platelet disorders. Platelets are essential for the blood clotting process, and any irregularities in their function can elevate the risk of bleeding or the formation of blood clots. Platelet aggregation devices help evaluate platelet function by measuring their ability to aggregate in response to different agonists. Technological advancements are allowing for automated, high-throughput testing with improved sensitivity and reproducibility. Due to its ability to aid in screening for platelet disorders and optimize antiplatelet therapy, there will be huge demand for platelet aggregation devices.
Platelet aggregation devices market growth is driven by growing incidence of cardiovascular diseases and associated increased use of antiplatelet drugs. Advanced features of newer devices are also improving workflow and easing the shift from manual to automated testing methods. However, market faces challenges like high costs of automated platelet analyzers as well as challenges to replace existing installed bases. Expanding applications such as monitoring antiplatelet therapy during pregnancy and developing standardized testing protocols for point-of-care use can offer growth opportunities.
Key features of the study
This report provides in-depth analysis of the global platelet aggregation devices market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global platelet aggregation devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sysmex Corporation, WerfenLife SA, Siemens Healthineers, Sentinel Ch. SpA, Haemonetics Corporation, Chrono-Log Corporation, Bio/Data Corporation, Aggredyne Inc., F. Hoffmann-La Roche Ltd., and Helena Laboratories Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global platelet aggregation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet aggregation devices market